Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector specializing in drug manufacturing, ...

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company specializing in cancer resistance ...

Autolus Therapeutics plc (NASDAQ: AUTL), a pioneering player in the biotechnology sector, offers a compelling opportunity for ...

Rapport Therapeutics, Inc. (RAPP), a promising player in the biotechnology sector, is drawing significant attention from ...

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, specializes in medical devices with a ...

MeiraGTx Holdings plc (NASDAQ: MGTX) is making waves in the biotechnology sector, particularly within the niche of genetic ...

Talking Medicines is using AI to analyse HCP conversations and identify the clinical and practical factors that may influence ...

For investors keen on the rapidly evolving healthcare sector, Personalis, Inc. (NASDAQ: PSNL) offers a compelling case, ...

Across these five interviews, several common investment themes emerge: opportunities created by undervalued UK equities, the ...

Finsbury Growth & Income Trust portfolio manager Nick Train discusses the trust’s long-term investment approach, AI and data ...

Norcros shares offer 29% potential upside as Cavendish highlights improving profits, strong brands and further growth opportunities.

Vietnam Enterprise Investments bought back 1,032,779 shares worth US$10.1 million in September, at an average 12.6% discount to NAV, as it continued its share buyback programme to manage the discount.